-

Why Polls About ICE and the Shooting of Renee Good Are So Hard to Parse
Numerous surveys in recent weeks have addressed ICE and the aftermath of her shooting in Minneapolis. The results are more complicated than they might seem.
-

A Senate Primary in Texas Tests the Future of Democratic Politics
Two of the Democrats’ rising stars, Jasmine Crockett and James Talarico, are seeing if a red state should be won courting disaffected Republicans or focusing on the party’s base.
-

Trump Rescinds Canada’s Invitation to Join His ‘Board of Peace’
The president appeared to be lashing out in response to stark, high-profile remarks by Prime Minister Mark Carney of Canada that rejected Mr. Trump’s efforts to dismantle the international order.
-

Uncharted Paths: Rediscovering the World Through Local Adventures
I remember it like it was yesterday, standing in front of the airport departures board, feeling the thrill of exploring a foreign land. But then, the pandemic hit, borders closed, and international adventures were put on pause. Suddenly, the idea of rediscovering the familiar turf of home didn’t sound so bad. Instead of hopping on…
-

HHS Compliance Deadline Approaching for Updated Part 2 Record Protections
Introduction and Summary – HHS issued a final rule modernizing 42 CFR Part 2 to implement the CARES Act and more closely align with HIPAA’s Privacy, Breach Notification, and Enforcement frameworks. The rule permits a single, prospective consent for Treatment, Payment, and Health Care Operations (TPO), expands HIPAA-consistent redisclosure permissions, amends notice of privacy practices…
-

New frontiers: How AI Is Transforming The Life Sciences Industry
The convergence of artificial intelligence (AI) and life sciences is no longer a distant promise. Companies operating in the sector are actively embracing the technology and are already achieving measurable results. In the following exclusive report from White & Case, in association with Mergermarket, this new reality is explored in depth. Drawing on a proprietary…
-

New frontiers: How AI is transforming the life sciences industry – Five Key Takeaways
With the learnings of this report in mind, five priorities emerge for companies aiming to translate their AI ambitions into concrete, lasting advantage…By: White & Case LLP
-

New frontiers: How AI is transforming the life sciences industry – Key Findings
1: AI is integral to business strategy – Three-quarters of life sciences companies say that AI is either crucial or very important to their business strategy. Within that, 68 percent of medical device companies and 56 percent of human pharma and biotech companies say AI is crucial to their strategy….By: White & Case LLP
-

New frontiers: How AI is transforming the life sciences industry – Conclusion: A Healthy Future For AI In The Life Sciences Arena
Embracing AI is a strategic imperative for companies across the life sciences value chain, with the technology now a prerequisite for innovation, efficiency and future-readiness. The overwhelming consensus from our survey respondents highlights the imminence of this change. Two thirds (66 percent) say AI’s impact on life sciences in the next 24 months will be…
-

The End of Pain and Suffering Damages in California Survival Actions
As of January 1, 2026, California law no longer allows for pain, suffering, or disfigurement damages in survival actions. This change marks the expiration of a temporary statutory amendment that allowed such damages, and a return to traditional California law….By: Gordon Rees Scully Mansukhani